Your browser doesn't support javascript.
loading
T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy.
Horgan, Claire; Mullanfiroze, Khushnuma; Rauthan, Archana; Patrick, Katharine; Butt, Naeem Akram; Mirci-Danicar, Oana; O'Connor, Olya; Furness, Caroline; Deshpande, Akshay; Lawson, Sarah; Broderick, Valerie; Evans, Pamela; Gibson, Brenda; Roberts, Wing; Ali, Salah; Galani, Sevasti; Kirkwood, Amy A; Jovanovic, Jelena; Dillon, Richard; Virgo, Paul; James, Beki; Rao, Kanchan; Amrolia, Persis J; Wynn, Robert F.
Afiliación
  • Horgan C; Royal Manchester Children's Hospital, Manchester, United Kingdom.
  • Mullanfiroze K; Great Ormond Street Hospital for Children, London, United Kingdom.
  • Rauthan A; Great Ormond Street Hospital for Children, London, United Kingdom.
  • Patrick K; Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom.
  • Butt NA; Bristol Royal Hospital for Children, Bristol, United Kingdom.
  • Mirci-Danicar O; Bristol Royal Hospital for Children, Bristol, United Kingdom.
  • O'Connor O; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Furness C; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Deshpande A; The Institute of Cancer Research, Sutton, United Kingdom.
  • Lawson S; Birmingham Children's Hospital, Birmingham, United Kingdom.
  • Broderick V; Birmingham Children's Hospital, Birmingham, United Kingdom.
  • Evans P; Children's Health Ireland at Crumlin, Dublin, Ireland.
  • Gibson B; Children's Health Ireland at Crumlin, Dublin, Ireland.
  • Roberts W; Royal Hospital for Children, Glasgow, United Kingdom.
  • Ali S; Great North Children's Hospital, Victoria Wing, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom.
  • Galani S; Leeds Children's Hospital, Clarendon Wing, Leeds General Infirmary, Leeds, United Kingdom.
  • Kirkwood AA; CR UK & UCL Cancer Trials Centre, UCL Cancer Institute, University College London, London, United Kingdom.
  • Jovanovic J; CR UK & UCL Cancer Trials Centre, UCL Cancer Institute, University College London, London, United Kingdom.
  • Dillon R; Department of Medical and Molecular Genetics, King's College London, Strand, London, United Kingdom.
  • Virgo P; Department of Medical and Molecular Genetics, King's College London, Strand, London, United Kingdom.
  • James B; Department of Immunology and Immunogenetics, North Bristol NHS Trust, Bristol, United Kingdom.
  • Rao K; Leeds Children's Hospital, Clarendon Wing, Leeds General Infirmary, Leeds, United Kingdom.
  • Amrolia PJ; Great Ormond Street Hospital for Children, London, United Kingdom.
  • Wynn RF; Great Ormond Street Hospital for Children, London, United Kingdom.
Blood Adv ; 7(10): 2155-2165, 2023 05 23.
Article en En | MEDLINE | ID: mdl-36649566
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped / Trastornos Mieloproliferativos Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped / Trastornos Mieloproliferativos Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos